NanJing Pharmaceutical Company Limited (600713.SS)
CNY 5.2
(-0.38%)
CNY 5.2
(-0.38%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.61 Billion CNY | 12.24% |
| 2022 | 1.62 Billion CNY | 7.12% |
| 2021 | 1.54 Billion CNY | 26.55% |
| 2020 | 1.16 Billion CNY | -2.33% |
| 2019 | 1.19 Billion CNY | 31.71% |
| 2018 | 966.5 Million CNY | 20.22% |
| 2017 | 753.88 Million CNY | 17.6% |
| 2016 | 641.05 Million CNY | 0.74% |
| 2015 | 362.54 Million CNY | 1.48% |
| 2014 | 593.57 Million CNY | 28.35% |
| 2013 | 472.87 Million CNY | -20.29% |
| 2012 | 486.12 Million CNY | 75.84% |
| 2011 | 246.6 Million CNY | 2.56% |
| 2010 | 291.99 Million CNY | 21.34% |
| 2009 | 284.45 Million CNY | 7.42% |
| 2008 | 251.74 Million CNY | -2.31% |
| 2007 | 260.91 Million CNY | 93.21% |
| 2006 | 138.3 Million CNY | 5.04% |
| 2005 | 132.16 Million CNY | 27.97% |
| 2004 | 103.46 Million CNY | -14.25% |
| 2003 | 119.85 Million CNY | 42.26% |
| 2002 | 84.24 Million CNY | -0.01% |
| 2001 | 80.72 Million CNY | -15.53% |
| 2000 | 90.68 Million CNY | 5.55% |
| 1999 | 95.56 Million CNY | 20.7% |
| 1998 | 78.28 Million CNY | 65.22% |
| 1997 | 47.38 Million CNY | 34.91% |
| 1996 | 35.12 Million CNY | -7.35% |
| 1995 | 37.9 Million CNY | 19.78% |
| 1994 | 31.64 Million CNY | 4.35% |
| 1993 | 30.33 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 383.48 Million CNY | -13.6% |
| 2024 Q2 | 195.66 Million CNY | -44.92% |
| 2024 Q3 | 317.42 Million CNY | 64.16% |
| 2023 Q2 | 433.01 Million CNY | 23.68% |
| 2023 Q4 | 446.19 Million CNY | 70.21% |
| 2023 FY | - CNY | 12.24% |
| 2023 Q1 | 350.11 Million CNY | 0.69% |
| 2023 Q3 | 262.14 Million CNY | -39.46% |
| 2022 Q1 | 312.77 Million CNY | -8.62% |
| 2022 Q2 | 381.74 Million CNY | 22.05% |
| 2022 Q3 | 277.81 Million CNY | -27.22% |
| 2022 Q4 | 347.7 Million CNY | 25.16% |
| 2022 FY | - CNY | 7.12% |
| 2021 Q1 | 269.05 Million CNY | -18.16% |
| 2021 FY | - CNY | 26.55% |
| 2021 Q2 | 334.7 Million CNY | 24.4% |
| 2021 Q3 | 287.86 Million CNY | -13.99% |
| 2021 Q4 | 342.29 Million CNY | 18.91% |
| 2020 Q4 | 328.73 Million CNY | 19.6% |
| 2020 FY | - CNY | -2.33% |
| 2020 Q1 | 171.75 Million CNY | -34.52% |
| 2020 Q2 | 291.33 Million CNY | 69.62% |
| 2020 Q3 | 274.86 Million CNY | -5.65% |
| 2019 Q1 | 222.24 Million CNY | 4.76% |
| 2019 Q3 | 320.5 Million CNY | 8.98% |
| 2019 FY | - CNY | 31.71% |
| 2019 Q4 | 262.31 Million CNY | -18.16% |
| 2019 Q2 | 294.09 Million CNY | 32.33% |
| 2018 Q2 | 205.42 Million CNY | -3.46% |
| 2018 Q3 | 178.61 Million CNY | -13.05% |
| 2018 FY | - CNY | 20.22% |
| 2018 Q4 | 212.13 Million CNY | 18.77% |
| 2018 Q1 | 212.77 Million CNY | 107.31% |
| 2017 Q3 | 183.1 Million CNY | -10.66% |
| 2017 Q1 | 173.25 Million CNY | 50.57% |
| 2017 Q4 | 102.64 Million CNY | -43.95% |
| 2017 Q2 | 204.95 Million CNY | 18.3% |
| 2017 FY | - CNY | 17.6% |
| 2016 Q3 | 147.5 Million CNY | 9.45% |
| 2016 Q1 | 157.69 Million CNY | 30.76% |
| 2016 FY | - CNY | 0.74% |
| 2016 Q4 | 115.06 Million CNY | -21.99% |
| 2016 Q2 | 134.76 Million CNY | -14.54% |
| 2015 FY | - CNY | 1.48% |
| 2015 Q2 | 132.65 Million CNY | -12.17% |
| 2015 Q4 | 120.6 Million CNY | -20.57% |
| 2015 Q3 | 151.83 Million CNY | 14.46% |
| 2015 Q1 | 151.03 Million CNY | -19.83% |
| 2014 Q3 | 124.92 Million CNY | 1.12% |
| 2014 Q4 | 188.38 Million CNY | 50.8% |
| 2014 FY | - CNY | 28.35% |
| 2014 Q1 | 111 Million CNY | -42.08% |
| 2014 Q2 | 123.53 Million CNY | 11.28% |
| 2013 Q4 | 191.64 Million CNY | 132.86% |
| 2013 Q1 | 64.38 Million CNY | -81.78% |
| 2013 FY | - CNY | -20.29% |
| 2013 Q3 | 82.3 Million CNY | -40.18% |
| 2013 Q2 | 137.57 Million CNY | 113.69% |
| 2012 Q1 | 47.08 Million CNY | -26.17% |
| 2012 Q2 | 98.92 Million CNY | 110.11% |
| 2012 Q3 | 65.82 Million CNY | -33.46% |
| 2012 Q4 | 353.42 Million CNY | 436.89% |
| 2012 FY | - CNY | 75.84% |
| 2011 Q4 | 63.77 Million CNY | -8.48% |
| 2011 Q2 | 92.64 Million CNY | 73.24% |
| 2011 Q1 | 53.47 Million CNY | -47.99% |
| 2011 FY | - CNY | 2.56% |
| 2011 Q3 | 69.68 Million CNY | -24.79% |
| 2010 Q2 | 85.48 Million CNY | 59.58% |
| 2010 Q1 | 53.56 Million CNY | -42.66% |
| 2010 Q4 | 102.82 Million CNY | 221.19% |
| 2010 FY | - CNY | 21.34% |
| 2010 Q3 | 32.01 Million CNY | -62.55% |
| 2009 Q3 | 27.53 Million CNY | -65.25% |
| 2009 FY | - CNY | 7.42% |
| 2009 Q4 | 93.42 Million CNY | 239.28% |
| 2009 Q1 | 35.74 Million CNY | -31.12% |
| 2009 Q2 | 79.25 Million CNY | 121.74% |
| 2008 Q2 | 84.18 Million CNY | 141.16% |
| 2008 FY | - CNY | -2.31% |
| 2008 Q4 | 51.88 Million CNY | 32.93% |
| 2008 Q3 | 39.03 Million CNY | -53.63% |
| 2008 Q1 | 34.9 Million CNY | -71.62% |
| 2007 Q4 | 123.01 Million CNY | 766.84% |
| 2007 Q1 | 28.57 Million CNY | -52.1% |
| 2007 FY | - CNY | 93.21% |
| 2007 Q2 | 61.68 Million CNY | 115.87% |
| 2007 Q3 | 14.19 Million CNY | -76.99% |
| 2006 Q1 | 28.2 Million CNY | -54.19% |
| 2006 FY | - CNY | 5.04% |
| 2006 Q4 | 59.65 Million CNY | 163.86% |
| 2006 Q3 | 22.6 Million CNY | -36.21% |
| 2006 Q2 | 35.44 Million CNY | 25.66% |
| 2005 Q4 | 61.56 Million CNY | 154.97% |
| 2005 Q1 | 23.53 Million CNY | 6.34% |
| 2005 Q2 | 34.5 Million CNY | 46.57% |
| 2005 Q3 | 24.14 Million CNY | -30.02% |
| 2005 FY | - CNY | 27.97% |
| 2004 Q2 | 23.67 Million CNY | 59.24% |
| 2004 FY | - CNY | -14.25% |
| 2004 Q1 | 14.87 Million CNY | -72.58% |
| 2004 Q3 | 13.17 Million CNY | -44.38% |
| 2004 Q4 | 22.13 Million CNY | 68.07% |
| 2003 FY | - CNY | 42.26% |
| 2003 Q4 | 54.23 Million CNY | 194.26% |
| 2003 Q1 | 12.02 Million CNY | -48.15% |
| 2003 Q2 | 36.34 Million CNY | 202.33% |
| 2003 Q3 | 18.42 Million CNY | -49.29% |
| 2002 Q3 | -2.13 Million CNY | -107.91% |
| 2002 FY | - CNY | -0.01% |
| 2002 Q1 | 12.24 Million CNY | 0.0% |
| 2002 Q2 | 27.03 Million CNY | 120.67% |
| 2002 Q4 | 23.18 Million CNY | 1183.93% |
| 2001 FY | - CNY | -15.53% |
| 2000 FY | - CNY | 5.55% |
| 1999 FY | - CNY | 20.7% |
| 1998 FY | - CNY | 65.22% |
| 1997 FY | - CNY | 34.91% |
| 1996 FY | - CNY | -7.35% |
| 1995 FY | - CNY | 19.78% |
| 1994 FY | - CNY | 4.35% |
| 1993 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 5.54 Billion CNY | 70.772% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 3.57 Billion CNY | 54.712% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 1.12 Billion CNY | -43.501% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 192.74 Million CNY | -740.139% |
| Aurora Optoelectronics Co.,Ltd. | -509.76 Million CNY | 417.664% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -14.11 Million CNY | 11575.156% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 157.93 Million CNY | -925.29% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.55 Billion CNY | -4.007% |